IGM Biosciences is laying off almost three-fourths of its staff after a crucial clinical study delivered poor results. The Mountain View company, whose current research focuses on autoimmune ...
MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...
IGM Biosciences Inc. (Nasdaq: IGMS) of Mountain View said Thursday that it plans to cut roughly 160 of its 220-person workforce and stop development of two drugs. Meanwhile, privately held Scribe ...
and IGM-7354, which will target the delivery of IL-15 with the goal of inducing immune cell stimulation and proliferation. The company was founded in 2010 and is headquartered in Mountain View, CA ...
The company was founded in 2010 and is headquartered in Mountain View, CA. Read More on IGMS: IGM Biosciences NewsMORE Related Stocks Indices ...
IGM Biosciences Background Information (This description is provided by the company.) Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused ...
MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback